A Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women

Overview

The aim of this trial is to investigate the effectiveness of a mobile health (mhealth) intervention to help overweight and obese women achieve appropriate gestational weight gain (GWG) for their pre-pregnancy body mass index (BMI). The goal of the intervention is to help women achieve GWG within the range recommended by the Institute of Medicine. The investigators propose an adaptive intervention that begins with an effective, yet low resource-intensive treatment and then provides incremental support and resources only to patients who need them. The intervention includes: 1) an mHealth tool allowing data to be automatically transmitted to a mobile website; 2) personalized text messages; and 3) personalized 1:1 telephone coaching sessions. The latter more intensive components are reserved for patients whose GWG is not within the IOM guidelines. The lifestyle intervention will be delivered through 1 telephone counseling session with a study dietician trained in motivational interviewing techniques, as well as through technology-based tools, automated text messages and weekly e-mails of core lifestyle intervention sessions. Personalized text messages and 1:1 telephone coaching sessions will be given to those who are not meeting the GWG guidelines. The lifestyle intervention will be compared to usual medical care. Maternal outcomes will be assessed shortly before delivery and at 6 weeks postpartum. Infant birthweight and weight at one year will also be assessed.

Full Title of Study: “Cluster Randomized Trial of a Mobile Health Intervention to Achieve Appropriate Gestational Weight Gain in Overweight/Obese Women”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: Double (Investigator, Outcomes Assessor)
  • Study Primary Completion Date: February 29, 2024

Interventions

  • Behavioral: Lifestyle Intervention
    • Behavioral lifestyle intervention

Arms, Groups and Cohorts

  • Experimental: Lifestyle Intervention
    • The goal of the intervention is to help women achieve GWG within the range recommended by the Institute of Medicine. The lifestyle intervention will be delivered through 1 telephone counseling session with a study dietician trained in motivational interviewing techniques, as well as through technology-based tools, automated text messages and weekly e-mails of core lifestyle intervention sessions. Personalized text messages and 1:1 telephone coaching sessions will be given to those who are not meeting the GWG guidelines.
  • No Intervention: Usual Care – Control
    • Usual Medical Care

Clinical Trial Outcome Measures

Primary Measures

  • Total gestational weight gain (GWG)
    • Time Frame: From 10 gestational weeks until delivery (approximately 40 gestational weeks)
  • Rate of total GWG
    • Time Frame: From 10 gestational weeks until delivery (approximately 40 gestational weeks)
  • Proportion of women meeting the Institute of Medicine’s GWG recommendation
    • Time Frame: From 10 gestational weeks until delivery (approximately 40 gestational weeks)

Secondary Measures

  • Trimester-specific weekly rate of GWG
    • Time Frame: 0 – 13 gestational weeks; 14 – 26 gestational weeks; 27 – 40 gestational weeks
  • GWG trajectory throughout pregnancy
    • Time Frame: From 10 gestational weeks until delivery (approximately 40 gestational weeks)
  • Change in moderate to vigorous physical activity (in MET hrs/week) as assessed by the Pregnancy Physical Activity Questionnaire (PPAQ)
    • Time Frame: Between 12 weeks and 33 weeks of pregnancy
    • We will assess change in moderate to vigorous physical activity between study assessments in pregnancy. The sports and exercise domain encompasses 10 PPAQ activities of moderate intensity (ranging 3.2 MET to 6 MET) and 2 PPAQ activities of vigorous intensity (6.5 MET and 7 MET). The volumes of all activities in the sports and exercise domain will be summed to arrive at an estimate of overall volume of moderate to vigorous intensity sports and exercise activity, expressed in MET hours per week. Higher levels of activity are generally associated with better outcomes. The distributions of all physical activity variables will be assessed for outliers.
  • Overall diet quality according to the Healthy Eating Index-2015 (HEI-2015)
    • Time Frame: Assessed at 12 weeks of pregnancy
    • The HEI-2015 reflects adherence to the 2015-2020 Dietary Guidelines for Americans; it is comprised of 13 components as well as an overall score. The scoring system ranges from 0 to 100, where higher values indicate a better diet quality.
  • Postpartum weight retention
    • Time Frame: Assessed at 6 weeks postpartum
  • The proportion of infants with appropriate birthweight (>10th and <90th percentile of sex-, gestational age-, and racial/ethnic-specific distribution)
    • Time Frame: Assessed at birth
  • Infant growth (BMI z-score)
    • Time Frame: From birth to 6 months of age

Participating in This Clinical Trial

Inclusion Criteria

  • Pregnant – Women receiving prenatal care at Kaiser Permanente San Francisco and Oakland and whose obstetric care clinicians consent to participate; – Pregravid BMI 25 to <40 (as determined from a measured pregravid weight in electronic medical record); – Has access to a smartphone and Wi-Fi; – Provides informed consent to participate. Exclusion Criteria:

  • Multiple births; – Planning to move out of the area during the study period; – Inability to speak, read, or understand English; – Placed on bed rest at time of enrollment; ->15 weeks' gestation at enrollment.

Gender Eligibility: Female

This study is only enrolling female participants.

Minimum Age: 18 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Kaiser Permanente
  • Collaborator
    • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Monique M Hedderson, Ph.D., (510) 891-3580, Monique.M.Hedderson@kp.org

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.